TY - JOUR
T1 - Genotype-phenotype correlation in contactin-associated protein-like 2 (CNTNAP-2) developmental disorder
AU - D'Onofrio, Gianluca
AU - Accogli, Andrea
AU - Severino, Mariasavina
AU - Caliskan, Haluk
AU - Kokotović, Tomislav
AU - Blazekovic, Antonela
AU - Jercic, Kristina Gotovac
AU - Markovic, Silvana
AU - Zigman, Tamara
AU - Goran, Krnjak
AU - Barišić, Nina
AU - Duranovic, Vlasta
AU - Ban, Ana
AU - Borovecki, Fran
AU - Ramadža, Danijela Petković
AU - Barić, Ivo
AU - Fazeli, Walid
AU - Herkenrath, Peter
AU - Marini, Carla
AU - Vittorini, Roberta
AU - Gowda, Vykuntaraju
AU - Bouman, Arjan
AU - Rocca, Clarissa
AU - Alkhawaja, Issam Azmi
AU - Murtaza, Bibi Nazia
AU - Rehman, Malik Mujaddad Ur
AU - Al Alam, Chadi
AU - Nader, Gisele
AU - Mancardi, Maria Margherita
AU - Giacomini, Thea
AU - Srivastava, Siddharth
AU - Alvi, Javeria Raza
AU - Tomoum, Hoda
AU - Matricardi, Sara
AU - Iacomino, Michele
AU - Riva, Antonella
AU - Scala, Marcello
AU - Madia, Francesca
AU - Pistorio, Angela
AU - Salpietro, Vincenzo
AU - Minetti, Carlo
AU - Rivière, Jean-Baptiste
AU - Srour, Myriam
AU - Efthymiou, Stephanie
AU - Maroofian, Reza
AU - Houlden, Henry
AU - Vernes, Sonja Catherine
AU - Zara, Federico
AU - Striano, Pasquale
AU - Nagy, Vanja
N1 - Funding: Open access funding provided by Università degli Studi di Genova within the CRUI-CARE Agreement. SS receives funding from the National Institutes of Health National Institute of Neurological Disorders and Stroke (K23NS119666). VN is supported by the Ludwig Boltzmann Gesellschaft core funding, the Austrian Science Fund (FWF): P 32924 and TAI 202 1000 Ideas Project.
PY - 2023/5/14
Y1 - 2023/5/14
N2 - Contactin-associated protein-like 2 (CNTNAP2) gene encodes for CASPR2, a presynaptic type 1 transmembrane protein, involved in cell–cell adhesion and synaptic interactions. Biallelic CNTNAP2 loss has been associated with “Pitt-Hopkins-like syndrome-1” (MIM#610042), while the pathogenic role of heterozygous variants remains controversial. We report 22 novel patients harboring mono- (n = 2) and bi-allelic (n = 20) CNTNAP2 variants and carried out a literature review to characterize the genotype–phenotype correlation. Patients (M:F 14:8) were aged between 3 and 19 years and affected by global developmental delay (GDD) (n = 21), moderate to profound intellectual disability (n = 17) and epilepsy (n = 21). Seizures mainly started in the first two years of life (median 22.5 months). Antiseizure medications were successful in controlling the seizures in about two-thirds of the patients. Autism spectrum disorder (ASD) and/or other neuropsychiatric comorbidities were present in nine patients (40.9%). Nonspecific midline brain anomalies were noted in most patients while focal signal abnormalities in the temporal lobes were noted in three subjects. Genotype–phenotype correlation was performed by also including 50 previously published patients (15 mono- and 35 bi-allelic variants). Overall, GDD (p < 0.0001), epilepsy (p < 0.0001), hyporeflexia (p = 0.012), ASD (p = 0.009), language impairment (p = 0.020) and severe cognitive impairment (p = 0.031) were significantly associated with the presence of biallelic versus monoallelic variants. We have defined the main features associated with biallelic CNTNAP2 variants, as severe cognitive impairment, epilepsy and behavioral abnormalities. We propose CASPR2-deficiency neurodevelopmental disorder as an exclusively recessive disease while the contribution of heterozygous variants is less likely to follow an autosomal dominant inheritance pattern.
AB - Contactin-associated protein-like 2 (CNTNAP2) gene encodes for CASPR2, a presynaptic type 1 transmembrane protein, involved in cell–cell adhesion and synaptic interactions. Biallelic CNTNAP2 loss has been associated with “Pitt-Hopkins-like syndrome-1” (MIM#610042), while the pathogenic role of heterozygous variants remains controversial. We report 22 novel patients harboring mono- (n = 2) and bi-allelic (n = 20) CNTNAP2 variants and carried out a literature review to characterize the genotype–phenotype correlation. Patients (M:F 14:8) were aged between 3 and 19 years and affected by global developmental delay (GDD) (n = 21), moderate to profound intellectual disability (n = 17) and epilepsy (n = 21). Seizures mainly started in the first two years of life (median 22.5 months). Antiseizure medications were successful in controlling the seizures in about two-thirds of the patients. Autism spectrum disorder (ASD) and/or other neuropsychiatric comorbidities were present in nine patients (40.9%). Nonspecific midline brain anomalies were noted in most patients while focal signal abnormalities in the temporal lobes were noted in three subjects. Genotype–phenotype correlation was performed by also including 50 previously published patients (15 mono- and 35 bi-allelic variants). Overall, GDD (p < 0.0001), epilepsy (p < 0.0001), hyporeflexia (p = 0.012), ASD (p = 0.009), language impairment (p = 0.020) and severe cognitive impairment (p = 0.031) were significantly associated with the presence of biallelic versus monoallelic variants. We have defined the main features associated with biallelic CNTNAP2 variants, as severe cognitive impairment, epilepsy and behavioral abnormalities. We propose CASPR2-deficiency neurodevelopmental disorder as an exclusively recessive disease while the contribution of heterozygous variants is less likely to follow an autosomal dominant inheritance pattern.
U2 - 10.1007/s00439-023-02552-2
DO - 10.1007/s00439-023-02552-2
M3 - Article
C2 - 37183190
SN - 0340-6717
JO - Human Genetics
JF - Human Genetics
ER -